Skip to content

The Clinical Efficacy of Electroacupuncture in the Treatment of Generalized Anxiety Disorder

The Clinical Efficacy of Electroacupuncture in the Treatment of Generalized Anxiety Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000475
Enrollment
Unknown
Registered
2026-03-05
Start date
2026-03-23
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Anxiety Disorder

Interventions

Sponsors

Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for Generalized Anxiety Disorder according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition; 2. Aged 18 to 70 years, with no restriction on gender; 3. Hamilton Anxiety Scale-14 is between 14 and 21 (inclusive of 14, exclusive of 21); 4. Hamilton Depression Scale-17 =17 and suicide factor score =2; 5. Agrees to participate in this study and signs the written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Individuals who have received anxiolytic medication treatment or used other hypnotic sedatives within 4 weeks before the start of the study, or those with anxiety caused by withdrawal reactions from anxiolytic medications; 2. Individuals with severe major diseases such as heart, liver, or kidney diseases; 3. Individuals with anxiety disorders caused by other physical diseases (e.g., hyperthyroidism, pheochromocytoma), or those with other primary mental disorders such as other anxiety disorders (social anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder, etc.), schizophrenia spectrum disorders, or bipolar affective disorders; 4. Individuals with intellectual or cognitive impairments who are unable to understand and complete the assessment scales; 5. Pregnant or breastfeeding women, or those planning pregnancy within the next 2 months; 6. Individuals with a history of drug abuse or addiction; 7. Individuals who have participated in other clinical trials in the past 2 months; 8. Individuals who have received other anxiolytic treatments in the past 2 months; 9. Individuals with metal allergies or severe fear of needles, or those with ulcers, abscesses, or skin infections at the acupuncture site, or those with implanted pacemakers; 10. Individuals who have received acupuncture or electroacupuncture treatment in the past 6 months; 11. Individuals with contraindications for magnetic resonance imaging (MRI), including the presence of metal objects in the body (e.g., heart stents, pacemakers, steel pins, or plates) or claustrophobia; 12. Left-handed individuals.

Design outcomes

Primary

MeasureTime frame
Change of Hamilton Anxiety Scale-14 Score ;

Secondary

MeasureTime frame
Change of Clinical Global Impression? Score ;Change of Generalized Anxiety Disorder-7 Score ;Change of Patient Health Questionnaire-9 Score ;Change of Insomnia Severity Index Score ;Change of Short Form 12 Health Survey Score ;Resting-state functional magnetic resonance imaging;Serum metabolomics;

Countries

China

Contacts

Public ContactLumin Liu

Longhua Hospital, Shanghai University of Traditional Chinese Medicine

beefllm@163.com13817684198

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026